The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, Physical therapy, Rheumatology and Clinical trial. His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with issues in Kappa and External validation. His Rheumatoid arthritis research includes themes of Placebo, Randomized controlled trial, Surgery and Arthritis.
His studies in Physical therapy integrate themes in fields like Epidemiology, Research design, Alternative medicine, Rheumatism and Severity of illness. The concepts of his Rheumatology study are interwoven with issues in Disease activity, Observational study, Cohort and Family medicine. He combines subjects such as Low back pain, Physical medicine and rehabilitation, Clinical research and Set with his study of Clinical trial.
Maarten Boers mainly investigates Internal medicine, Rheumatoid arthritis, Physical therapy, Clinical trial and Rheumatology. The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine. His work deals with themes such as Placebo, Disease and Arthritis, which intersect with Rheumatoid arthritis.
His studies deal with areas such as Osteoarthritis, Alternative medicine, Intensive care medicine, Construct validity and Severity of illness as well as Physical therapy. His research integrates issues of Psychological intervention, Systematic review, Medical physics and Delphi method in his study of Clinical trial. His Rheumatology research includes elements of Rheumatism, Adverse effect and Family medicine.
His main research concerns Internal medicine, Rheumatoid arthritis, Physical therapy, Clinical trial and Rheumatology. The various areas that Maarten Boers examines in his Internal medicine study include Gastroenterology and Surgery. His work on Prednisolone and Radiography as part of general Surgery study is frequently linked to Cobra, therefore connecting diverse disciplines of science.
His Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Rheumatism, Adverse effect, Disease and Arthritis. His biological study spans a wide range of topics, including Osteoarthritis, Patient-reported outcome, Content validity, Construct validity and Low back pain. His work deals with themes such as Systematic review, Outcomes research, Delphi method and Set, which intersect with Clinical trial.
Maarten Boers mostly deals with Physical therapy, Rheumatoid arthritis, Internal medicine, Clinical trial and Intensive care medicine. His Physical therapy research is multidisciplinary, incorporating elements of Quality of life, Rheumatism, Construct validity, Severity of illness and Low back pain. His work on Antirheumatic Agents as part of general Rheumatoid arthritis study is frequently linked to In patient, bridging the gap between disciplines.
His Internal medicine study frequently links to other fields, such as Abatacept. The various areas that Maarten Boers examines in his Clinical trial study include Osteoarthritis, Delphi method, Gerontology, Position paper and Research design. His Intensive care medicine research is multidisciplinary, incorporating perspectives in Alternative medicine, Context and Medication adherence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
Beverley J Shea;Jeremy M Grimshaw;George A Wells;Maarten Boers.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)
The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus.
Arianne P. Verhagen;Henrica C.W. de Vet;Robert A. de Bie;Alphons G.H. Kessels.
Journal of Clinical Epidemiology (1998)
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.
Beverley J. Shea;Candyce Hamel;George A. Wells;Lex M. Bouter.
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
Maarten Boers;Arco C Verhoeven;Harry M Markusse;Mart Afj van de Laar.
The Lancet (1997)
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.
Harm Van Tinteren;Otto S. Hoekstra;Egbert F. Smit;Jan H.A.M. Van Den Bergh.
The Lancet (2002)
Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III
Nicholas Bellamy;John Kirwan;Maarten Boers;Peter Brooks.
The Journal of Rheumatology (1997)
The OMERACT filter for Outcome Measures in Rheumatology.
M Boers;P Brooks;C V Strand;P Tugwell.
The Journal of Rheumatology (1998)
COBRA Combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention
Robert B. M. Landewé;Maarten Boers;Arco C. Verhoeven;Rene Westhovens.
Arthritis & Rheumatism (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: